TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2025
Voltar para busca
Dado oficial do USPTO
MICROBAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
13/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
20/07/2015
Data de registro
28/06/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/07/2023
Última transação
13/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
09
Localização do titular
Novara (NO), IT
Examinador
DICKEY, ERICA
Unidade examinadora
M30
Localização atual
TMO LAW OFFICE 112
Titulares e representantes
Titulares
PROBIOTICAL S.P.A.
PROBIOTICAL S.P.A.
Representantes
Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Micro-organisms culture for medical uselactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesincludingintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humansreducing inflammation and pain; Supplementsdietary supplementsfor medical use and baby foodall the above containing preparations and products resulting from the processing of microorganismsparticularly metabolites obtained from the processing of probiotic bacterial cultures; Supplementsdietary supplements for medical use and baby foodall the above containing liquidsoliddried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposesall the foregoing being for medical and veterinary use only
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/07/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
28/06/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/12/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/12/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/07/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/02/2023
ES8R
TEAS SECTION 8 RECEIVED
27/12/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/06/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
31/10/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/10/2016
AMD7
SEC 7 REQUEST FILED
01/08/2016
PAPER RECEIVED
01/08/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
28/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/04/2016
PUBO
PUBLISHED FOR OPPOSITION
12/04/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/03/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/03/2016
ALIE
ASSIGNED TO LIE
02/03/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
02/03/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/01/2016
ALIE
ASSIGNED TO LIE
26/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/10/2015
GNRT
NON-FINAL ACTION E-MAILED
30/10/2015
CNRT
NON-FINAL ACTION WRITTEN
30/10/2015
DOCK
ASSIGNED TO EXAMINER
29/10/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
25/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/07/2015
NWAP
NEW APPLICATION ENTERED
23/07/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MICROBAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.